Retrospective Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Feb 6, 2022; 10(4): 1198-1205
Published online Feb 6, 2022. doi: 10.12998/wjcc.v10.i4.1198
Table 1 Comparison of the general conditions of the two groups of patients during the perioperative period
Group
Case
Operation time (min)
Intraoperative blood loss (mL)
PCNL group4092.68 ± 6.39148.79 ± 10.03
mPCNL group40150.42 ± 8.4884.25 ± 6.54
t value-34.39234.090
P value< 0.001< 0.001
Table 2 Comparison of renal function indexes of the two groups of patients before and after treatment
Group
Cr (μmol/L)
BMG (ng/L)
RBP (mg/L)
Before therapy
After treatment
Before therapy
After treatment
Before therapy
After treatment
PCNL group124.35 ± 8.11124.36 ± 7.423.16 ± 1.013.15 ± 0.2255.34 ± 5.6855.38 ± 6.03
mPCNL group124.33 ± 7.45124.37 ± 5.883.15 ± 0.983.17 ± 0.3855.32 ± 4.9755.35 ± 7.49
t value0.011-0.0070.045-0.2880.0170.020
P value0.4950.4970.4820.3870.4930.492
Table 3 Comparison of pain and clearance rate between the two groups
Group
Case
VAS
Clearance rate, n (%)
PCNL group403.52 ± 0.6140 (100.00)
mPCNL group402.27 ± 0.2239 (97.50)
t/χ2 value12.1911.013
P value< 0.0010.314
Table 4 Comparison of the incidence of complications between the two groups of patients
Group
Case
Urine extravasation
Difficulty breathing
Damage to surrounding organs
Total incidence
PCNL group402013
mPCNL group401001
χ2 value1.053
P value0.305
Table 5 Comparison of postoperative recovery of the two groups of patients
Group
QOL
Qmax
1 mo after treatment
3 mo after treatment
1 mo after treatment
3 mo after treatment
PCNL group1.95 ± 0.341.76 ± 0.2412.86 ± 1.4415.38 ± 2.54
mPCNL group1.68 ± 0.521.55 ± 0.3115.73 ± 1.7218.36 ± 2.19
t value2.7493.3888.0925.620
P value0.0070.001< 0.001< 0.001